EmBiology (formerly EMBiology) is a web-based Software as a service tool from Elsevier in which researchers can view biological relationships between entities, such as genes, proteins, and cells.[1]
Launched in 2023, EmBiology queries a Biological Knowledge Graph with 1.4 million entities connected by 15.7 million relationships.[1] It uses a Sankey diagram to visualize search findings, and displays "snippets" of text from relevant scientific literature.
EmBiology was originally launched as EMBiology in 2005 as a life science bibliographic database in a partnership with Ovid Technologies as a smaller version of Embase.[2]
EmBiology Data sources include:[3]
- 7.2 million Full-text articles from 936 Elsevier journals and 939 non-Elsevier journals
The following biological concepts are included in EmBiology:[4]
More information Concept, Description ...
Concept |
Description |
Drugs & chemicals |
Naturally occurring metabolites, small molecules found in cell, drugs (incl. small molecules & biologics) |
Diseases |
Health conditions and disease terms |
Proteins |
Represents both genes and the gene products, including proteins and miRNAs |
Functional classes |
Proteins classes based on biological function |
Protein complexes |
One or more polypeptides that form a complex via physical interactions |
Genetic variant |
Variants searchable by SNPID and text |
Cells |
Mammalian cell types & cell lines |
Cell Process |
Biological processes (e.g., apoptosis, inflammation) |
Organs |
Mammalian organ types |
Tissues |
Mammalian tissue types |
Viruses |
An agent that causes infectious diseases |
Clinical parameter |
Measured parameters of the human body used in clinical practice |
Treatment |
Non-chemical treatments and environmental conditions |
Cell object |
Organelles, cell structural components |
Close
The following biological relationships are included in EmBiology[5]
More information Relation, Description ...
Relation |
Description |
Example |
Expression |
Changes protein abundance by affecting levels of transcript or protein stability |
MDM2 has a negative "Expression" relationship with TP53 |
miRNA Effect |
Inhibitory effect of an miRNA on its mRNA target |
miR-30 has a negative "miRNAEffect" relationship with TP53 |
Promoter Binding |
Binds to the promoter of a gene |
FOXC1 has a positive "PromoterBinding" relationship with MMP7 |
Regulation |
Changes activity by an unknown mechanism (may be direct or indirect) |
SOCS3 has a positive "Regulation" relationship with diabetes mellitus |
Direct Regulation |
Influences activity by direct physical interaction |
BRCA1 has a "DirectRegulation" relationship with BARD1 |
Binding |
Direct physical interaction between two molecules |
FANCD2 has a "Binding" relationship with BRCA1 |
Protein Modification |
Changes the modification of the target molecule, usually by direct interaction |
SRC has a "ProtModification" relationship with GRB2 |
Biomarker |
Identification of proteins/complexes/functional classes/metabolites that are prognostic or diagnostic biomarkers for a disease |
Lung cancer has a "Biomarker" relationship with IL6 |
Genetic Change |
Genetic changes such as gene deletions, amplifications, mutations or epigenetic changes |
Lung cancer has a "GeneticChange" relationship with ALK |
Quantitative Change |
Changes in abundance/activity/expression of a gene/protein/small molecule in a disease state |
Breast cancer has a positive "QuantitativeChange" relationship with AGK |
State Change |
Changes in a protein's post-translational modification status or alternative splicing events |
Breast cancer has a "StateChange" relationship with estrogen receptor |
Functional Assoc. |
Between a disease and a cellular process or another disease |
Chronic pancreatitis has a "FunctionalAssociation" relationship with pancreatic cancer |
Chemical Reaction |
Either enzyme catalysed or spontaneous chemical reaction |
CYP3A has a "ChemicalReaction" relationship with ticagrelor |
Molecular Synthesis |
Changes the concentration of the target |
CYP3A has a "MolSynthesis" relationship with midazolam |
Molecular Transport |
Changes the localization of the target |
Tamoxifen has a positive "MolTransport" relationship with MAPK3 |
Clinical Trial |
Clinical trials conducted for a drug against a disease (from CT.gov) |
Tamoxifen has a positive "Clinical Trial" relationship with breast cancer |
Cell Expression |
Expression of proteins within or on the surface of a cell |
Hepatocyte has a "CellExpression" relationship with EGFR |
Close
References